LongevityMap Gene

Gene details

HGNC symbol
DRD4 
Aliases
D4DR 
Common name
dopamine receptor D4 
Description
This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats; the sequence shown contains four repeats. [provided by RefSeq, Jul 2008]
Cytogenetic Location
11p15.5
UCSC Genome Browser
View 11p15.5 on the UCSC genome browser
OMIM
126452
Ensembl
ENSG00000069696
UniProt/Swiss-Prot
A0A0G2JM26_HUMAN
Entrez Gene
1815
UniGene
99922
1000 Genomes
1000 Genomes

Homologs in model organisms

Danio rerio
drd4a
Danio rerio
drd4b
Drosophila melanogaster
TyrR
Drosophila melanogaster
TyrRII
Mus musculus
Drd4
Rattus norvegicus
Drd4

Studies (2)

Significant/Non-significant: 1/1

Study 1

Longevity Association
Significant
Population
American (Caucasian)
Study Design
Surviving participants of a 30-year-old population-based health survey (N = 310; age range, 90–109 years; the 90+ Study) were genotyped/resequenced at the DRD4 gene and compared with a European ancestry-matched younger population (N = 2902; age range, 7–45 years)
Conclusions
Oldest-old population carrying the DRD4 7R allele was higher relative to the younger sample (p = 3.5 × 10−9). And DRD4 7R genotype was strongly correlated with increased levels of physical activity.
Indentifier
DRD4 7R
Reference

    Study 2

    Longevity Association
    Non-significant
    Population
    Italian (Southern)
    Study Design
    A two-stage case-control study was performed to identify the association between longevity and variation of in homeostasis regulation pathway genes. 317 SNPs in 104 genes were analyzed in 78 cases (≥90 years, median age 98 years, 42 females) and 71 controls (<90 years, median age 67 years, 32 females) in stage 1. Then, 31 candidate SNPs identified in stage 1 (π markers = 0.1) were analyzed in an independent sample composed by 288 cases (≥90 years, median age 92 years, 163 females) and 554 controls (<90 years, median age 67 years, 277 females).
    Conclusions
    After adjustment for multiple testing, no significant association was identified between various SNPs and longevity.
    Indentifier
    rs936461
    Reference